Trevena (NASDAQ:TRVN) Earns Sell Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research report sent to investors on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Other research analysts have also recently issued research reports about the company. JMP Securities reaffirmed a market outperform rating and set a $2.00 price […]